EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop

Aisar Atrakchi, Raechel Puglisi iD, Joel Bercu iD, Jennifer Cheung, Andreas Czich iD, Roland Froestchl iD, Karen Davis-Bruno, Robert H Heflich iD, Tetyana Kobets iD, Timothy J McGovern iD, Anthony Lynch iD, Max Selby und 5 weitere

Mutagenesis · 2026

DOI: 10.1093/mutage/geag011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mutagenesis, 2026. Verfasst von Aisar Atrakchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: US Food and Drug Administration/Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States. Hauptthemen laut MEDLINE: Mutagens, Nitrosamines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Detection of N-nitrosamines (NA) in pharmaceuticals became a point of interest due to the mutagenic and carcinogenic potential of some compounds of this class, and their identification as nitrosated forms of marketed drugs, otherwise known as NA Drug Substance-Related Impurities (NDSRIs). The Ames test is used to assess the mutagenic potential of drug impurities, including NAs. Concerns over the sensitivity of the Ames test, as recommended in Organization for Economic Co-operation and Development Test Guideline 471, in predicting the rodent carcinogenic potential of NAs has prompted optimization of several test parameters used for detecting the mutagenicity of NAs (e.g. methods used for metabolic activation and the selection of tester strains). In order to discuss optimal Ames test conditions for the evaluation of NAs, including NDSRIs, the Office of New Drugs in the US Food and Drug Administration’s Center for Drug Evaluation and Research and the Health and Environmental Sciences Institute’s Genetic Toxicology Technical Committee co-organized and co-sponsored a workshop entitled “Nitrosamines: Ames Data Review and Method Development Workshop”. The workshop featured five sessions addressing charge questions pertinent to the Ames test conditions and performance through the presentation of data and panel discussions. This report outlines the key takeaway points from the workshop.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutagensNitrosaminesAnimalsHumansCarcinogensDrug ContaminationMutagenicity TestsUnited StatesUnited States Food and Drug Administration

Stichwörter der Autor:innen

Ames testgenetic toxicology assays for risk assessmentnitrosamines

Substanzen

CarcinogensMutagensNitrosamines

Autor:innen und Institutionen

  • US Food and Drug Administration/Center for Drug Evaluation and Research, Silver Spring, MD 20993, United States.
  • Health and Environmental Sciences Institute, Washington, DC 20005, United States.
  • Gilead Sciences, Inc., Nonclinical Safety and Pathobiology, Foster City, CA 94404, United States.
  • Pfizer Research, Development, and Medical, Groton, CT 06370, United States.
  • Sanofi, R&D Translational Medicine Preclinical Safety, Frankfurt D-69526, Germany.
  • BfArM (Federal Institute for Drugs and Medical Devices), Licensing 2, Unit Pharmaceutical Biotechnology, Genetic and Reproductive Toxicology, Bonn 53175, Germany.

ORCID-Profile: Raechel Puglisi, Joel Bercu, Andreas Czich, Roland Froestchl, Robert H Heflich, Tetyana Kobets, Timothy J McGovern, Anthony Lynch, Maik Schuler, Alisa Vespa, Rhys Whomsley, Connie L Chen

Zitieren

APA

Atrakchi, A., Puglisi, R., Bercu, J., Cheung, J., Czich, A., Froestchl, R., Davis-Bruno, K., Heflich, R. H., Kobets, T., McGovern, T. J., Lynch, A., Selby, M., Schuler, M., Silveira, G. O., Vespa, A., Whomsley, R., & Chen, C. L. (2026). Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop. Mutagenesis. https://doi.org/10.1093/mutage/geag011

Vancouver

Atrakchi A, Puglisi R, Bercu J, Cheung J, Czich A, Froestchl R, et al. Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop. Mutagenesis. 2026. doi:10.1093/mutage/geag011

BibTeX
@article{Atrakchi2026,
  author = {Atrakchi, Aisar and Puglisi, Raechel and Bercu, Joel and Cheung, Jennifer and Czich, Andreas and Froestchl, Roland and Davis-Bruno, Karen and Heflich, Robert H and Kobets, Tetyana and McGovern, Timothy J and Lynch, Anthony and Selby, Max and Schuler, Maik and Silveira, Gabriela De Oliveira and Vespa, Alisa and Whomsley, Rhys and Chen, Connie L},
  title = {Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop},
  journal = {Mutagenesis},
  year = {2026},
  doi = {10.1093/mutage/geag011}
}
Kostenlos starten →